Transmembrane activator and caml interactor (Taci): Another potential target for immunotherapy of multiple myeloma?
10.3390/cancers12041045
Saved in:
Main Authors: | Xu, S., Lam, K.-P. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Article |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/196175 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Transmembrane activator and CAML interactor (TACI) : another potential target for immunotherapy of multiple myeloma?
by: Xu, Shengli, et al.
Published: (2021) -
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023) -
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023) -
Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
by: Razak, R.A., et al.
Published: (2016) -
Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival
by: Reghunathan, R., et al.
Published: (2014)